Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hashimoto

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Physical Review Letters|January 15, 2021
Phase Locking between Two All-Optical Quantum MemoriesFumiya Okamoto, Mamoru Endo, Mikihisa Matsuyama, et al.
Biochemical and Biophysical Research Communications|June 12, 2016
Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse modelYosuke Hashimoto, Minoru Tada, Manami Iida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Cell culture in esophageal squamous cell carcinoma and the association with molecular markersYutaka Shimada, Masato Maeda, Go Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Clinical significance of dysadherin expression in gastric cancer patientsYutaka Shimada, Seiji Yamasaki, Yosuke Hashimoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2018
A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated LiposomesTaro Shimizu, Amr S Abu Lila, Yoshino Kawaguchi, et al.
Diagnostic Pathology|June 23, 2010
Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell linesCristian M Ortiz, Tetsuo Ito, Yosuke Hashimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2017
Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian ModelYosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, et al.
Chembiochem : a European Journal of Chemical Biology|October 15, 2014
Chemistry, properties, and in vitro and in vivo applications of 2'-O-methoxyethyl-4'-thioRNA, a novel hybrid type of chemically modified RNAYota Saito, Yosuke Hashimoto, Mai Arai, et al.
Pharmacology Research & Perspectives|October 8, 2016
Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibodyYosuke Hashimoto, Yumi Kawahigashi, Tomoyuki Hata, et al.
Oncology|October 2, 2004
Prognostic significance of dysadherin expression in esophageal squamous cell carcinomaYutaka Shimada, Yosuke Hashimoto, Takatsugu Kan, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Physical Review Letters|January 15, 2021
Phase Locking between Two All-Optical Quantum MemoriesFumiya Okamoto, Mamoru Endo, Mikihisa Matsuyama, et al.
Biochemical and Biophysical Research Communications|June 12, 2016
Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse modelYosuke Hashimoto, Minoru Tada, Manami Iida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Cell culture in esophageal squamous cell carcinoma and the association with molecular markersYutaka Shimada, Masato Maeda, Go Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Clinical significance of dysadherin expression in gastric cancer patientsYutaka Shimada, Seiji Yamasaki, Yosuke Hashimoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2018
A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated LiposomesTaro Shimizu, Amr S Abu Lila, Yoshino Kawaguchi, et al.
Diagnostic Pathology|June 23, 2010
Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell linesCristian M Ortiz, Tetsuo Ito, Yosuke Hashimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2017
Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian ModelYosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, et al.
Chembiochem : a European Journal of Chemical Biology|October 15, 2014
Chemistry, properties, and in vitro and in vivo applications of 2'-O-methoxyethyl-4'-thioRNA, a novel hybrid type of chemically modified RNAYota Saito, Yosuke Hashimoto, Mai Arai, et al.
Pharmacology Research & Perspectives|October 8, 2016
Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibodyYosuke Hashimoto, Yumi Kawahigashi, Tomoyuki Hata, et al.
Oncology|October 2, 2004
Prognostic significance of dysadherin expression in esophageal squamous cell carcinomaYutaka Shimada, Yosuke Hashimoto, Takatsugu Kan, et al.
Pageof 8